O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study
- 31 July 2005
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 49, S37
- https://doi.org/10.1016/s0169-5002(05)80237-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: